⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1355666 | 0.86 | — | — | |
| SCHEMBL29064652 | 0.85 | PPM1B (0.30) | — | |
| SCHEMBL28863508 | 0.85 | — | — | |
| SCHEMBL1356375 | 0.83 | — | — | |
| SCHEMBL3039803 | 0.82 | POLA1 (0.34) | — | |
| SCHEMBL1355698 | 0.81 | — | — | |
| SCHEMBL3033173 | 0.80 | POLA1 (0.36) | — | |
| SCHEMBL211984 | 0.80 | — | — | |
| SCHEMBL1549079 | 0.79 | — | — | |
| SCHEMBL9285389 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117999296-A | Composition and photosensitive composition | 东京应化工业株式会社 | 2024-05-07 | — | — | CN | disclosed |
| CN-117980346-A | Composition and photosensitive composition | 东京应化工业株式会社 | 2024-05-03 | — | — | CN | disclosed |
| CN-117908326-A | Photosensitive composition | 东京应化工业株式会社 | 2024-04-19 | — | — | CN | disclosed |
| CN-117908327-A | Composition and photosensitive composition | 东京应化工业株式会社 | 2024-04-19 | — | — | CN | disclosed |
| CN-117178001-A | Photocurable composition | 东京应化工业株式会社 | 2023-12-05 | — | — | CN | disclosed |
| CN-112088185-B | Resin composition, sealing sheet, and sealing body | 琳得科株式会社 | 2023-09-26 | — | — | CN | disclosed |
| CN-112292435-B | Sealant composition, sealing sheet, and sealing body | 琳得科株式会社 | 2023-09-01 | — | — | CN | disclosed |
| CN-114479138-A | Preparation process of high-temperature-resistant strong cross membrane capable of preventing asphalt from deforming | 江苏求实塑业有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-10732173-B2 | Use of aldehyde dehydrogenase as biomarker for beta-cell dysfunction and loss | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2020-08-04 | — | — | US | disclosed |
| US-20190265229-A1 | USE OF ALDEHYDE DEHYDROGENASE AS BIOMARKER FOR BETA-CELL DYSFUNCTION AND LOSS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-08-29 | — | — | US | disclosed |
| US-8389740-B2 | Process for preparing ionic liquids by anion exchange | BASF SE (DE) | 2013-03-05 | — | — | US | disclosed |
| US-20100217010-A1 | PROCESS FOR PREPARING IONIC LIQUIDS BY ANION EXCHANGE | BASF SE (DE) | 2010-08-26 | — | — | US | disclosed |
| EP-2217574-A1 | METHOD FOR PRODUCING IONIC LIQUIDS BY ANION EXCHANGE | BASF SE (DE) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009059934-A1 | METHOD FOR PRODUCING IONIC LIQUIDS BY ANION EXCHANGE | BASF SE (DE) | 2009-05-14 | — | — | WO | disclosed |
| EP-1385816-B1 | METHOD FOR PURIFYING AN ORGANIC SOLVENT FOR THE PURPOSE OF ABSORPTION OF MALEIC ACID ANHYDRIDE | BASF SE (DE) | 2009-04-15 | — | — | EP | disclosed |
| WO-2006027070-A1 | METHOD FOR THE PRODUCTION OF HETEROCYCLIC QUATERNARY AMMONIUM COMPOUNDS AND/OR GUANIDINE COMPOUNDS HAVING HIGH PURITY | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | WO | disclosed |
| EP-1385816-A1 | METHOD FOR PURIFYING AN ORGANIC SOLVENT FOR THE PURPOSE OF ABSORPTION OF MALEIC ACID ANHYDRIDE | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-04 | — | — | EP | disclosed |
| WO-2002085834-A1 | METHOD FOR PURIFYING AN ORGANIC SOLVENT FOR THE PURPOSE OF ABSORPTION OF MALEIC ACID ANHYDRIDE | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-31 | — | — | WO | disclosed |
| EP-1208148-A1 | PLASTICISER FOR POLYMERIC COMPOSITIONS | PERSTORP AB (SE) | 2002-05-29 | — | — | EP | disclosed |
| WO-2001000722-A1 | PLASTICISER FOR POLYMERIC COMPOSITIONS | PERSTORP AB (SE) | 2001-01-04 | — | — | WO | disclosed |